NCT06736795 Progressive Achilles Loading Via Clinician E-support
| NCT ID | NCT06736795 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ruth Chimenti |
| Condition | Achilles Tendon Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2025-08-20 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2025-08-20 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized controlled trial with individuals who have Achilles tendon pain. This study is designed to identify an effective rehabilitation program for Achilles tendon pain that expands access to care for military personnel and to predict treatment response. Limited or delayed access to healthcare can exacerbate the severity of pain and duration of disability due to AT. This is particularly relevant for individuals deployed to battlefield settings or are being seen in busy military treatment facilities. Therefore, it is crucial to identify efficient and effective treatment pathways that maximize healthcare access and facilitate a rapid and pain-free return to full duty.
Eligibility Criteria
Inclusion Criteria: * Pain localized to the Achilles tendon (insertion or midportion) * AT pain greater than or equal to 3/10 with tendon-loading exercise Exclusion Criteria: * Younger than 18 years of age or older than 60 years of age * BMI \> 45 kg/m2 * Pain primarily due to a differential diagnosis, including paratendonitis, bursitis (retrocalcaneal or subcutaneous), posterior ankle impingement or os trigonum, irritation or neuropathy of the sural nerve, plantaris tendon involvement) * Presence of a partial Achilles tendon tear or rupture on imaging or a history of Achilles tendon rupture that was verified by surgical or conservative management * Attended physical therapy for AT in the past 3 months * History of steroid injection to lower extremity tendons/fascia, ESWT or any injection to the Achilles tendon region in the past 3 months * History of taking fluoroquinolones in the past 6 months * History of surgery or invasive procedure for AT on side enrolling for treatment * Diagnosed systemic conditions affecting the foot and ankle (e.g., rheumatoid arthritis, ankylosing spondylitis), endocrine disorder with complications (e.g., uncontrolled Type I or II diabetes, diabetic peripheral neuropathy), connective tissue disorder (e.g., Marfan's syndrome, Ehlers Danlos), or pregnancy * At high risk for falls (four step square test \>15 seconds) * Refusal of randomization or unable or uninterested in completing virtual visits with a webcam or smart phone or completing quizzes and surveys
Contact & Investigator
Ruth L Chimenti, PT, PhD
PRINCIPAL INVESTIGATOR
University of Iowa
Frequently Asked Questions
Who can join the NCT06736795 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Achilles Tendon Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06736795 currently recruiting?
Yes, NCT06736795 is actively recruiting participants. Contact the research team at chimenti-lab@uiowa.edu for enrollment information.
Where is the NCT06736795 trial being conducted?
This trial is being conducted at Iowa City, United States, Fort Cavazos, United States.
Who is sponsoring the NCT06736795 clinical trial?
NCT06736795 is sponsored by Ruth Chimenti. The principal investigator is Ruth L Chimenti, PT, PhD at University of Iowa. The trial plans to enroll 160 participants.